The first wave of COVID-19 did not cause ...
Type de document :
Article dans une revue scientifique: Article original
PMID :
URL permanente :
Titre :
The first wave of COVID-19 did not cause longer wait times in head and neck cancer. Experience of a French expert center.
Auteur(s) :
Vanderhaegen, T. [Auteur]
Hôpital Claude Huriez [Lille]
Pierache, A. [Auteur]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Mortuaire, Geoffrey [Auteur]
Lille Inflammation Research International Center (LIRIC) - U995
Rysman, B. [Auteur]
Hôpital Claude Huriez [Lille]
Nicot, Romain [Auteur]
Advanced Drug Delivery Systems (ADDS) - U1008
Chevalier, D. [Auteur]
Hôpital Claude Huriez [Lille]
Mouawad, F. [Auteur]
Hôpital Claude Huriez [Lille]
Hôpital Claude Huriez [Lille]
Pierache, A. [Auteur]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Mortuaire, Geoffrey [Auteur]
Lille Inflammation Research International Center (LIRIC) - U995
Rysman, B. [Auteur]
Hôpital Claude Huriez [Lille]
Nicot, Romain [Auteur]
Advanced Drug Delivery Systems (ADDS) - U1008
Chevalier, D. [Auteur]
Hôpital Claude Huriez [Lille]
Mouawad, F. [Auteur]
Hôpital Claude Huriez [Lille]
Titre de la revue :
European Annals of Otorhinolaryngology, Head and Neck Diseases
Nom court de la revue :
Eur Ann Otorhinolaryngol Head Neck Dis
Numéro :
139
Pagination :
261-267
Éditeur :
Elsevier
Date de publication :
2022-09-29
ISSN :
1879-730X
Mot(s)-clé(s) :
Multidisciplinary tumor board
Wait time
Head and neck cancer
SARS-CoV-2
COVID-19
Wait time
Head and neck cancer
SARS-CoV-2
COVID-19
Discipline(s) HAL :
Sciences du Vivant [q-bio]
Résumé en anglais : [en]
Background
Head and neck cancers (HNC) have poor survival prognosis, as tumors are often diagnosed at advanced stages in patients consulting late. The first lockdown linked to the 1st wave of COVID-19 (Coronavirus Disease ...
Lire la suite >Background Head and neck cancers (HNC) have poor survival prognosis, as tumors are often diagnosed at advanced stages in patients consulting late. The first lockdown linked to the 1st wave of COVID-19 (Coronavirus Disease 2019) disrupted consultation schedules in France. Objective The principal aim of the present study was to analyze consultation wait time in HNC during and after lockdown, in our university expert oncology reference center, to disclose any increase in treatment wait time. Methods A single-center retrospective study included patients with a first diagnosis of HNC. Three groups were distinguished: “lockdown”, “post-lockdown”, and a “control” group (corresponding to a reference period 1 year earlier). Intervals between first oncologic consultation and multidisciplinary tumor board (FC-MTB) and between MTB and first treatment (MTB-T) were assessed. Results One hundred and seven patients were included in the control group, 60 in the lockdown group and 74 in the post-lockdown group. There was no increase in median FC-MTB interval (respectively 35, 29 and 28 days) between the lockdown and post-lockdown groups compared to the control group (respectively P = 0.2298 and P = 0.0153). Likewise, there was no increase in MTB-T interval (27, 20 and 26 days respectively) (P = 0.4203). Conclusion No increase in wait times was observed during the lockdown and post-lockdown periods in our center.Lire moins >
Lire la suite >Background Head and neck cancers (HNC) have poor survival prognosis, as tumors are often diagnosed at advanced stages in patients consulting late. The first lockdown linked to the 1st wave of COVID-19 (Coronavirus Disease 2019) disrupted consultation schedules in France. Objective The principal aim of the present study was to analyze consultation wait time in HNC during and after lockdown, in our university expert oncology reference center, to disclose any increase in treatment wait time. Methods A single-center retrospective study included patients with a first diagnosis of HNC. Three groups were distinguished: “lockdown”, “post-lockdown”, and a “control” group (corresponding to a reference period 1 year earlier). Intervals between first oncologic consultation and multidisciplinary tumor board (FC-MTB) and between MTB and first treatment (MTB-T) were assessed. Results One hundred and seven patients were included in the control group, 60 in the lockdown group and 74 in the post-lockdown group. There was no increase in median FC-MTB interval (respectively 35, 29 and 28 days) between the lockdown and post-lockdown groups compared to the control group (respectively P = 0.2298 and P = 0.0153). Likewise, there was no increase in MTB-T interval (27, 20 and 26 days respectively) (P = 0.4203). Conclusion No increase in wait times was observed during the lockdown and post-lockdown periods in our center.Lire moins >
Langue :
Anglais
Audience :
Internationale
Établissement(s) :
Université de Lille
Inserm
CHU Lille
Inserm
CHU Lille
Collections :
Date de dépôt :
2022-12-08T01:14:50Z
2023-02-22T09:24:40Z
2023-02-22T11:47:05Z
2023-02-22T09:24:40Z
2023-02-22T11:47:05Z